Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02439437 · ClinicalTrials.gov registry record · NA

Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02439437 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 28 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02439437, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study looks at whether a coping skills training program can help women manage pain and stress after breast surgery, and lower the risk of developing chronic pain. This coping skills program includes eight training sessions that are done by telephone. These sessions will focus on strategies for dealing with pain and stress, and how to apply these strategies to subjects' own experiences.

Conditions Studied

Interventions

  • BEHAVIORAL Psychosocial Intervention

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2015-10-08
Est. Completion 2020-01-06
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02439437

The ClinicalTrials.gov registry entry for NCT02439437 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Intervention is the first listed.

NCT02439437 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02439437 about?

NCT02439437 is a clinical study titled "Targeted Pain Coping Skills Training (PCST) for Prevention and Treatment of Persistent Post-Mastectomy Pain". This study looks at whether a coping skills training program can help women manage pain and stress after breast surgery, and lower the risk of developing chronic pain. This coping skills program includes eight training sessions that are done by telephone. These sessions will focus on strategies for ...

What is the current status of trial NCT02439437?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-10-08. Estimated completion is 2020-01-06.

What conditions does trial NCT02439437 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02439437?

The interventions under investigation include: Psychosocial Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02439437?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02439437 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.